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PUltrasound and Vascular Function
oninvasive Low-Frequency Ultrasound
nergy Causes Vasodilation in Humans
iyoshi Iida, MD, Huai Luo, MD, Kohsuke Hagisawa, MD, Takashi Akima, MD,
rediman K. Shah, MD, FACC, Tasneem Z. Naqvi, MD, FACC, Robert J. Siegel, MD, FACC
os Angeles, California
OBJECTIVES We evaluated the potential vasodilator effects of transcutaneous low-frequency ultrasound
(US) in human brachial arteries.
BACKGROUND Recent data show that transthoracic low-frequency US energy results in canine coronary
artery vasodilation.
METHODS Brachial artery diameters were measured before and after low-frequency US (29 kHz, 1.4
W/cm2) exposure using US imaging with a linear-array transducer. We assessed the time
course of diameter changes after US in 20 subjects. In 10 of 20 subjects, brachial artery
flow-mediated vasodilation (FMD) was measured to compare the effect of US to a standard
method of evaluating endothelial function.
RESULTS Significant vasodilation was seen after 2 min of US compared with baseline values. At 5 min
of US, the brachial artery diameter increased by 4.1%. In addition, the arteries continued to
dilate after US exposure. At 3 min after US there was a 5.4%, and at 5 min after US a 6.0%
increase in vessel diameter (p  0.001). These diameters returned to baseline dimensions
about 20 min after stopping US. Ultrasound-mediated vasodilation and percentage FMD
showed good correlation (r  0.87; p  0.001).
CONCLUSIONS This is the first study to demonstrate that noninvasive transcutaneous low-frequency US
energy dilates human brachial arteries. This arterial vasodilator effect has a rapid onset (within
2 min), lasts about 20 min, and is similar in magnitude to that of FMD. The vasodilator effect
of US may have diagnostic and therapeutic potential in patients with or at risk for vascular
disease. (J Am Coll Cardiol 2006;48:532–7) © 2006 by the American College of
























mltrasound (US) is generally used for diagnostic imaging
sing MHz frequencies. It is also being developed as a
herapeutic tool related to the direct mechanical energy
ffects of low-frequency (kHz) US. Low-frequency US
nergy accelerates thrombolysis by itself or when used in
onjunction with a thrombolytic agent in vitro and in vivo
1–7). Low-frequency US energy also improves tissue per-
usion and reverses acidosis in ischemic tissues in animal
odels (7–9). Thus, low-frequency US may have a potential
asodilator effect in humans. Invasive, catheter-delivered,
ow-frequency (20 kHz) high-intensity US has previously
een shown to cause vasodilation in peripheral and coronary
rteries in animals and humans (10–12). Recently our group
howed that noninvasive, transcutaneous low-frequency US
nergy results in canine coronary vasodilation. Within 5 min
f US exposure, the cross-sectional area (CSA) in canine
oronary arteries increased by 21%. This vasodilator effect
as reversible and similar in magnitude to that induced by
itroglycerin (13). In this study, we evaluate if transcutane-
us low-frequency US has a vasodilator effect on human
rachial arteries in vivo. In addition, to investigate the
echanism of the vasodilator effect, we compare the effect
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006, accepted March 16, 2006.f low-frequency US to brachial artery flow-mediated vaso-
ilation (FMD), which is a standard method for the
valuation of endothelial-dependent vasomotor function.
ETHODS
wenty participants were enrolled in this study (mean age 
EM: 36  2 years; 19 men). One had hypertension on
reatment, 1 had borderline dyslipidemia, 2 had a family
istory of coronary artery disease, and 1 was a current
moker. The Cedars-Sinai Medical Center Institutional
eview Board approved the study, and all participants
rovided written informed consent.
tudy protocol. Low-frequency transcutaneous US (29
Hz, 1.4 W/cm2) was applied for 1 to 5 min to identify the
nset as well as magnitude of the US vasodilator effect in
uman subjects. Because endothelial function is affected by
ood, caffeine, and time of day (circadian rhythm), the study
as performed in the morning in a fasting state. After
aseline US imaging of the brachial artery, low-frequency
ranscutaneous US was applied to the arm for 1 min, 2 min,
r 3 min in 10 subjects. Images were obtained in this group
fter 1, 2, or 3 min of US. In 20 subjects, US was applied
ontinuously for 5 min. In the group receiving 5 min of
ontinuous US, subsequent vascular imaging and measure-
ents of the brachial artery were repeated immediately after
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August 1, 2006:532–7 Ultrasound-Induced Vasodilation in Humanshe cessation of US exposure. Brachial artery percentage
ltrasound-mediated vasodilation (%UMD) was defined as
highest diameter in these 3 different time points after US
xposure  baseline diameter)/(baseline diameter). Brachial
rtery Doppler was also performed 30 s, 3 min, and 5 min
fter stopping the application of US to assess changes in
ow.
In 10 of the 20 subjects, the low-frequency US study was
epeated to assess the reproducibility of the vasodilator
ffect. In this study group, the brachial artery diameter was
easured every 5 min until the arterial diameter decreased
o its baseline value. Brachial artery flow-mediated vasodi-
ation (FMD) was also measured in these subjects to
ompare the effect of low-frequency US to the standard
ethod for evaluation of endothelial-dependent vasomotor
unction.
ltrasound image acquisition and determination of FMD.
he brachial artery was imaged with an HDI-5000 US
ystem and broadband L12-5 linear-array transducer (Phil-
ps Medical, Bothell, Washington). Studies were performed
n a quiet, temperature-controlled (23°C) room. The sub-
ects were positioned supine with the arm in a comfortable
osition for imaging of the brachial artery, which was
maged above the antecubital fossa. A transverse plane with
he use of color flow Doppler facilitated location of the
rachial artery, which was then imaged in the longitudinal
lane. A segment with clear anterior and posterior intimal
nterfaces between the lumen and vessel wall was selected
or continuous two-dimensional (2D) grayscale imaging.
he 2D image was optimized using the depth function in
he US system. Imaging depth and gain settings were kept
onstant throughout the study. The baseline image was then
cquired. Brachial artery diameter was measured at the same
ime in the cardiac cycle using electrocardiogram gating
uring image acquisition. The onset of the R-wave was used
o identify end-diastole, which corresponds to the minimum
iameter of the artery. A pulse-wave (PW) Doppler was
btained from the mid-artery. Flow velocity and velocity-
ime integral (VTI) were calculated on an average of
onsecutive 3 heart cycles at baseline and after US exposure.
bsolute flow (ml) during 1 heart cycle was calculated by
ultiplying the cross-sectional area and VTI. Brachial
rtery diameter measurements were performed off line by 2
ardiologists using a semiautomatic quantitative analysis
ystem after the procedure. The second cardiologist per-
orming the measurements was blinded to the data obtained
y the first cardiologist. All diagnostic US data were
Abbreviations and Acronyms
NO  nitric oxide
FMD  flow-mediated vasodilation
UMD  ultrasound-mediated vasodilation
US  ultrasound
VTI  velocity-time integraligitized, and off-line measurements were performed by the
t
sericis Echo Review application (Camtronics Medical Sys-
ems, Hartland, Wisconsin). All the data were measured
wice, and final values were averaged. The inter- and
ntra-observer coefficients of variation (CV) for brachial
rtery diameters were 0.9% and 0.5%, respectively. The
ean error of brachial artery diameters between measure-
ents was 0.028 mm, and the absolute error ranged from
.002 to 0.086 mm.
The method for determining brachial artery FMD fol-
owed the guidelines of the International Brachial Artery
eactivity Task Force (14). In brief, after measurement of
aseline brachial artery diameter, arterial flow was inter-
upted for 5 min by a blood pressure cuff placed on the
roximal forearm at least 50 mm Hg higher than arterial
ressure. Using electrocardiographic triggering, end-
iastolic images were captured at baseline and for 2 min
fter cuff deflation. Brachial artery %FMD induced by
eactive hyperemia was expressed as relative change from
aseline (%FMD  [(60-s maximum diameter  baseline
re-cuff diameter)/(baseline pre-cuff diameter)]  100).
ranscutaneous US device. The US system consists of a
enerator and a US transducer delivering 29-kHz pulsed-
ave US (Timi3 Systems, Santa Clara, California). The
ransducer, which transmits US energies through a water-
lled bladder, was placed over the upper arm covering the
rachial artery as shown in Figure 1. The transducer-
adiating area is about 60 cm2, and the surface was coupled
o the skin with US transmission gel (Graham-Field, Bay
hore, New York). US maximum intensity is approximately
.4 W/cm2 (corresponding to spatial-average, temporal-
verage intensity of about 0.12 W/cm2). The US signal is
ulsed wave, and the US is on 30% of the time and off 70%
f the time (30% duty cycle). The pulse repetition frequency
f the ultrasound system is 25 Hz, and its temporal
aximum US power is about 23 W. The shape of the US
eld diverges and covers the brachial artery. Because of the
iverging beam shape the maximum US intensity is at the
igure 1. The ultrasound transducer was put on the upper arm covering
2he brachial artery. The transducer-radiating area is about 60 cm and the
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Ultrasound-Induced Vasodilation in Humans August 1, 2006:532–7ntrance point of US, i.e., on the skin surface. The output
f the transducer was measured with a calibrated hydro-
hone (model 8103, Brüel & Kjær, Nærum, Denmark) in
ccordance with the existing guidelines and standards
15–17).
kin temperature measurements. Skin temperature mea-
urements were made during 5 min of US exposure in 10
ubjects. The skin temperature directly beneath the US probe
as measured with a thermometer (HH202A, Omega Engi-
eering, Stamford, Connecticut).
tatistical analysis. Continuous variables were expressed as
ean  SEM or percentage change. Paired t test was used to
igure 2. Percentage brachial artery diameter changes before and imme-
iately after ultrasound (US) exposure in different time durations. There is
ignificant vasodilation after 2, 3, and 5 min of ultrasound exposure
ompared with the baseline values. Images of the brachial artery were
igitized and measured using the Vericis Echo Review application
Camtronics Medical Systems, Hartland, Wisconsin). The R-wave of the
lectrocardiogram was used to time the measurements of vascular diameter.
p  0.01; †p  0.001; mean  SEM (%), n  10.
igure 3. A representative case of B-mode ultrasound image on brachial art
iameter was measured off-line after the procedure by the Vericis Echo Review
emiautomatic quantitative analysis system (3.938 mm at baseline and 4.567 mssess changes in brachial arterial diameter, Doppler measure-
ents, and skin temperature before and after US exposure.
epeated measures analysis of variance (RMANOVA) was
sed to assess changes in brachial artery diameter across the
time points. Contrasts were used to compare each
ost-US mean with the baseline mean; the significance level
or each contrast was adjusted to 0.0167 by the Bonferroni
ethod. Pearson’s correlation coefficient was calculated to
how the relation of the US effect to brachial artery %FMD
nd the reproducibility of the US effect. Unpaired t test was
sed to compare brachial artery %UMD to %FMD and
esponders to minimal responders divided by US effect. A p
alue of 0.05 was considered statistically significant.
ESULTS
ltrasound measurements. Percentage brachial artery di-
meter changes before and immediately after US exposure
ccording to different durations of US exposure are shown
n Figure 2. There is significant vasodilation after 2, 3, and
min of US exposure compared to the baseline values. The
kin temperature did not change before and after 5 min of
S exposure (30.5  0.44°C to 30.7  0.41°C; p  NS;
 10).
A representative case of a B-mode vascular US image
efore and after 5 min of US exposure is shown in Figure 3.
he brachial artery dilates from 3.938 mm at baseline to
.567 mm after 5 min of US exposure. Figure 4 shows the
ime course of changes in mean brachial artery diameter in
esponse to US exposure. The RMANOVA model was
ignificant and each time comparison to baseline had a
value of 0.001. Mean brachial artery diameter increased
rom 4.06  0.08 mm at baseline to 4.30  0.09 mm at 5
in after US exposure. After 5 min of US exposure, mean
baseline (left) and after 5 min ultrasound exposure (right). Brachial arteryery at
application (Camtronics Medical Systems, Hartland, Wisconsin) using a
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August 1, 2006:532–7 Ultrasound-Induced Vasodilation in Humansrachial artery diameter increased by 4.1% (p  0.001
ompared with baseline). The arteries further dilated to
.4% at 3 min after stopping US (p  0.001) and continued
o dilate to 6.0% at 5 min after stopping US exposure (p 
.001). In 10 subjects, the brachial artery diameter was
easured every 5 min until it returned to baseline. The
rachial artery decreased to baseline measurements at 21 
min after US exposure.
Individual variations were observed in response to US
xposure. Some of the subjects responded by augmenting
ell to US and some of them did not respond. We defined
ubjects who increased the brachial artery diameter by 0.1
m as nonresponders (0.02  0.02 mm; n  5) and those
ith 0.1 mm increase in diameter as responders (0.28 
.03 mm; n  15). Nonresponders were different in age
ompared with responders (45  3 years vs. 33  2 years,
espectively; p  0.05). In addition, 3 of 5 nonresponders
ad other cardiovascular risk factors. Namely, 1 nonre-
ponder had hypertension, 1 had dyslipidemia, and 1 was a
moker.
oppler study. Overall, VTI did not change significantly
ut tended to slightly decrease after 5 min of US exposure
ompared with baseline (18.3  1.6 cm to 17.6  1.8 cm;
 NS; n  20). Conversely, pulsatility index (PI), which
s an index of peripheral vascular resistance calculated as
peak systolic velocity minimum diastolic velocity)/(mean
elocity), had a small nonsignificant increase (6.6  1.4 to
.5  1.3; p  NS; n  20). Absolute flow did not change
efore and after 5 min of US exposure (2.2 0.2 ml/beat to
.3  0.2 ml/beat; p  NS; n  20). However, individual
ariations were observed in response to US exposure in VTI.
ive of 20 subjects increased more than 9% (range 9.4% to
7.5%) in VTI compared to baseline. All of these 5 cases
ilated their brachial artery (responders) after US exposure.
igure 4. The brachial artery diameter before and after 5 min of low-
requency ultrasound (US) exposure. On the vertical axis is brachial artery
iameter; on the horizontal axis is the time after ultrasound exposure
immediately, 3 min, and 5 min after ultrasound). Percentages were
xpressed as relative changes from baseline ([diameter change/baseline
iameter]  100). *p  0.001; mean  SEM (mm), n  20.nother 5 of 20 subjects had essentially no or minimal
U
dhange in their VTI (5%, range 4.9% to 3.6%); 1 was a
onresponder and 4 were responders. The other 10 of 20
ubjects had a decrease in VTI of more than 9% (38.5% to
9.3%); 4 were nonresponders and 6 were responders.
omparison with FMD and reproducibility of US effect.
n 10 of 20 subjects, in addition to the response to US we
easured brachial artery FMD to compare with the stan-
ard method for evaluating endothelial function. Mean
rachial artery %FMDwas 5.9 1.0% (range 2.9% to 12.6%)
nd mean brachial artery %UMD was 5.6  1.1% (range
.3% to 11.6%) in these repeated subjects (n  10). There
as a similar change in %FMD and in %UMD (5.9 1.0%
s. 5.6  1.1%; p  NS). In addition, there was a good
orrelation between brachial artery %UMD and %FMD, as
hown in Figure 5 (r  0.87; p  0.001). The absolute
ifferences between UMD and FMD ranged from 0.003 to
.181 mm (mean 0.102 mm) for brachial artery diameters
nd 0.05% to 2.76% (mean 1.38%) for percentage change.
he reproducibility of low-frequency US vasodilator effect
n the same patients at 2 different time intervals was also
ood (r  0.80; p  0.005). The absolute differences
etween 2 different measurements ranged from 0 to 0.60
m (mean 0.10 mm) for brachial artery diameters and
.19% to 5.72% (mean 1.64%) for %UMD. The coefficients
f variation between two different time studies were
.7% for brachial artery diameters and 16% for %UMD
easurements.
ISCUSSION
his is the first study to demonstrate that noninvasive
ranscutaneous low-frequency US energy dilates human
rteries. There are also no earlier data regarding the dura-
ion of vasodilator effect after low-frequency US exposure in
ivo. We found that this vasodilator effect has a rapid onset
within 2 min) and that it lasts about 20 min. A few studies
igure 5. The correlation between brachial artery %UMD and %FMD.
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Ultrasound-Induced Vasodilation in Humans August 1, 2006:532–7ave demonstrated that invasive catheter-delivered low-
requency US dilates coronary and peripheral arteries in
nimals and humans (10–12). In 1 study of noninvasive
ranscutaneous low-frequency US in dogs, it was shown by
ntravascular coronary US that US energy dilates coronary
rteries (13). In that study, the vasodilator effect was
pparent after 30 s (4.6% increase in diameter) of US
xposure, after 2 min (8.2% increase in diameter) of US, and
urther after 5 min (10% increase in diameter) of US in dogs’
oronary arteries. These findings in a canine model are
onsistent with our data regarding the onset of US vasodi-
ation in humans.
Although the mechanism of vasodilation induced by
ow-frequency US is not entirely known, it is likely to be due
o a local vasodilator effect related to stimulation of endo-
helial cells by local vibrations from low-frequency US.
ascular endothelial cells normally respond with several
echanical stresses, including shear tension and compres-
ion. Ultrasound is a propagating pressure wave that trans-
ers mechanical energy to tissues. Krasovitski and Kimmel
18) have found that shear stress is induced at a tissue wall
n an US field. Suchkova et al. (8) have suggested that US
an be viewed as a method to expose endothelial cells to
ontrolled mechanical stress. Shear stress is particularly
mportant in regulating endothelial cell function, because it
lters cell morphology, metabolism, and gene expression.
luid shear stress induces a rapid, large, and sustained
ncrease in nitric oxide (NO) activity. In the very acute
etting (seconds) of shear stress, calcium-activated potas-
ium channels open and increase NO production (19,20).
itric oxide contributes to vessel dilation by inhibiting
ascular smooth muscle constriction (21). Several factors
ppear to be operant for the increase in NO in response to
hear stress. Acute changes appear to be sensitive to the
ncrease in intracellular calcium which happens as potassium
on channels open. Over minutes, phosphorylation of en-
othelial NO synthase owing to shear stress also occurs, and
his has been hypothesized as being important for sustained
eneration of NO (22).
Recently, it has been demonstrated that low-frequency
S causes vasodilation and improves tissue perfusion in
schemic limbs (7,8) and myocardium (9) in animals. It
eems likely that the US-induced capillary dilation and
nhanced tissue perfusion are due to an NO-dependent
echanism, because these effects were completely blocked
y NO inhibition. Furthermore, Altland et al. (23) demon-
trated that low-frequency (27 kHz continuous wave) US
ncreases human umbilical vein endothelial cell NO syn-
hase activity and NO synthesis in vitro. In that study, the
ells showed a rapid response in NO synthesis with a
aximum increase during 1 to 5 min after US exposure.
he NO synthesis declined to baseline 30 min after US
xposure. The duration of the vasodilator effect in the present
tudy was about 20 min and thus parallels the increases in NO
n that earlier study. This suggests that the vasodilator effect ects not only through ion-channel mechanism but also through
nzymatic phosphorylation.
The mechanism of vasodilation due to US is not the same
s that due to FMD, which is recognized as a method for
valuating endothelial function by the release of NO (24).
low-mediated dilation is caused by an increase in volume
ow, and our data does not support this as a mechanism for
S-induced vasodilation. In most of the cases, absolute flow
id not change before and after US exposure. There was a
eterogeneous response of brachial artery flow velocities to
S. Because the US energy only affects the segment exposed
o US (as seen in Fig. 1), flow velocities are determined by
he resistance vessels in the hand and forearm. However,
here is a good correlation between the magnitude of the US
ffect and FMD in the present study. It seems likely that
oth are mediated by an NO-dependent mechanism, be-
ause NO is an important regulator of vasomotor tone.
asodilation secondary to smooth muscle relaxation from a
asoinhibitory effect of US can not be excluded in the
resent study.
Analysis of individual responses to low-frequency US
howed that nonresponders (vasodilation 0.1 mm; n  5)
ere different in age than responders (vasodilation 0.1
m; n 15) (45 3 years vs. 33 2 years; p 0.05). The
nding that age affects the response to low-frequency US is
lso consistent with the good correlation between UMD
nd FMD in the current study, because FMD has been
hown to correlate with age (25). Mean %FMD in nonre-
ponders was 3.8% in the present study. This was almost
ame value as for the group of subjects between 50 and 54
ears old in the Framingham Study (25). In addition, 3 of
he 5 nonresponders had cardiovascular risk factors. These
actors could have affected the age differences between the
ramingham study and our study.
A meta-analysis of 211 selected articles (11,984 patients)
eporting on FMD and cardiovascular risk factors was
ecently published (26). In that meta-analysis, mean bra-
hial artery %FMD was 6.8% in low-risk subjects divided
nto tertiles of Framingham risk score (27) (mean risk score
.1% risk/10 years; mean age 30 years). Mean brachial artery
FMD in our study was 5.9  1.0%. The %FMD of our
tudy subjects is similar to that of the low-risk subjects in
he meta-analysis. Because our study subjects are slightly
lder than the low-risk subjects in the meta-analysis (mean
ge 36 years vs. 30 years, respectively), there is a possibility
hat brachial artery %FMD is lower in our study subjects
han in low-risk subjects in meta-analysis. These data
uggest that our study group is representative of a low-risk
atient population.
The safety of low-frequency US for animals using this
ntensity (1.4 W/cm2) and frequency (29 kHz) has already
een shown in previous reports (1,2). High-intensity US
an heat tissue (7,28), and tissue heating can cause vasodi-
ation (29). However, previous studies using this same
evice have demonstrated that vasodilation as well as other
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August 1, 2006:532–7 Ultrasound-Induced Vasodilation in Humansncrease in tissue temperature (1,9,13). In this study, we
easured skin temperature at the site of US exposure using
thermometer. There was no evidence of any heating
uring US exposure to the subjects’ arm, and the skin
emperature did not change during US exposure.
There are limitations of measurement of brachial artery
iameter by the semiautomatic quantitative analysis system.
owever, the reproducibility of the low-frequency US
asodilator effect in the same patients at 2 different time
ntervals was good (r  0.80; p  0.005; mean absolute
ifferences 1.64% for %UMD). This suggests that there is a
onsistent vasodilator effect of low-frequency US in human
rachial arteries and that the methodology of this study
sing a semiautomatic quantitative analysis system is rea-
onable. Factors that significantly affect the reproducibility
f UMD may be due to physiologic variables and second-
rily due to technical errors.
In conclusion, the findings of the current study indicate
hat transcutaneous low-frequency US energy has a vasodi-
ator effect with rapid onset (within 2 min) and a duration of
bout 20 min. The vasodilator effect of low-frequency US
ay have diagnostic as well as potential therapeutic appli-
ations in patients with vascular disease or dysfunction.
dditional studies will be needed to address this issue.
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